Home Healthcare IT Thailand Cell and Gene Therapy Manufacturing QC Market Share & Growth Report By[2028]

Thailand Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028

Thailand Cell and Gene Therapy Manufacturing QC Market Size

According to Straits Research analysis, the Thailand Cell and Gene Therapy Manufacturing QC Market was valued at USD 46.77 Million in 2024 and is projected to reach USD 116.67 Million by 2028, expanding at a CAGR of 25.7% during the forecast period. This dynamic growth is predominantly driven by applications in medical biotechnology, valuable in personalized medicine, oncology, and genetic disorders. Supporting industries such as agriculture and energy also utilize genetic engineering technologies, influencing the demand for cell and gene therapy manufacturing. The market experiences emerging trends in green production and sustainability, encouraging bio-based solutions and low-carbon practices. Technological advancements enable efficient gene editing techniques, fostering market growth. Thailand's rapid adoption of these innovative technologies propels its export potential. Moving forward, Thailand poises itself as a competitive player in the cell and gene therapy manufacturing QC market, leveraging its technological prowess and green manufacturing approaches.

Thailand Cell and Gene Therapy Manufacturing QC Market Highlights

  • Within the Therapy Type category, Cell Therapy dominated in 2024 in terms of market size contribution.
  • Over the forecast period, Gene Therapy is forecasted to deliver the fastest growth, positioning it as the most lucrative Therapy Type segment.
  • In 2024, Thailand accounted for 2.09% of the global cell and gene therapy manufacturing qc market size.
  • By 2028, United States is expected to lead the global cell and gene therapy manufacturing qc market in terms of market size.
  • Within Asia Pacific, China is projected to dominate the regional cell and gene therapy manufacturing qc market size by 2028.
  • India is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 58503 Million by 2028.
  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2028
Historical Period 2021-2023
Forecast Period 2025-2028
Market Size In 2024 USD 46.77 Million
Market Size In 2028 USD 116.67 Million
Largest segment Cell Therapy
Fastest segment Gene Therapy
Units Revenue in USD Million
CAGR 25.7% (2025-2028)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Thailand Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type

Segmentation Covered

Segments Sub Segments
Therapy Type
  1. Cell Therapy
  2. Gene Therapy
Cell Therapy
  1. CAR-T
  2. CAR-NK
  3. B-Cell
  4. Other
CAR-T
  1. Autologous CAR-T
  2. Allogeneic CAR-T
Gene Therapy
  1. Viral
  2. Non-Viral
Viral
  1. AAV
  2. Lentiviral vectors
  3. Other
Scale
  1. Pre commercial/ R&D Manufacturing
  2. Commercial Scale Manufacturing
Mode
  1. Contract Manufacturing
  2. In-house Manufacturing
Workflow
  1. Cell Processing
  2. Cell Banking
  3. Fill & Finish Operations
  4. Raw Material Testing
  5. Vector Production
  6. Other Workflows
Process
  1. Upstream Processes
  2. Downstream Processes
End User
  1. Pharmaceutical Companies
  2. Biopharmaceutical / Biotechnological Companies
  3. Contract Manufacturing Organizations
Pharmaceutical Companies
  1. Small Size
  2. Medium Size
  3. Large Size
Biopharmaceutical / Biotechnological Companies
  1. Small Size
  2. Medium Size
  3. Large Size
Contract Manufacturing Organizations
  1. Small Size
  2. Medium Size
  3. Large Size
Technology Type
  1. Fluorescence-Activated Cell Sorting (FACS)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Chromatography
  4. Next-Generation Sequencing (NGS)
  5. Polymerase Chain Reaction (PCR)
  6. Others 

Cell and Gene Therapy Manufacturing QC Market- Geographics


WhatsApp
Chat with us on WhatsApp